AJAaron Jamison

Aaron Jamison

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aaron Jamison has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Raman Malhotra

    Corneoplastic Unit, Queen Victoria Hospital NHS Foundation Trust, East Grinstead, UK

    4 shared publications
  • Ewan G. Kemp

    Scottish Ocular Oncology Service, Tennent Institute of Ophthalmology, Glasgow, UK

    3 shared publications
  • Paul Cauchi

    Scottish Ocular Oncology Service, Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK

    3 shared publications
  • Vikas Chadha

    Scottish Ocular Oncology Service, Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK

    3 shared publications
  • D F Gilmour

    Glasgow Centre for Ophthalmic Research, Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, Scotland, UK

    2 shared publications
  • Paul Cauchi

    Scottish Ocular Oncology Service Tennent Institute of Ophthalmology Gartnavel General Hospital Glasgow UK

    2 shared publications

Latest Publications

  • Horizontal shortening of the lower eyelid margin in facial nerve palsy

    by Aaron Jamison, Bhupendra C. K. Patel, Raman Malhotra

    Background/Objectives To determine whether horizontal lower eyelid margin length shortens following facial nerve palsy (FNP). Subjects/Methods A single-centre retrospective audit of lower eyelid margin horizontal length, measuring from the lower lacrimal punctum to lateral canthal angle with a straight plastic ruler, with the eyelid on gentle stretch (‘punctum-to-canthus (PC) distance’), recorded in all FNP patients reviewed in July–September 2021. Affected and fellow eyes were compared using parametric testing. Results Forty-one patients were reviewed. Seventeen were excluded due to previous surgery that would lengthen (e.g., periosteal flap) or shorten (e.g., lateral tarsal strip) the lower eyelid margin. Of the remaining 24, mean age was 52.5 years (range, 27–79) and 54% were female. Mean PC distance was significantly shorter in affected eyes (26.0 mm, range: 22–34 mm) compared to fellow eyes (27.5 mm, 24–35 mm) (paired t-test, T(23) = 6.06, p < 0.00001). Mean difference between both eyes’ PC distance was 1.5 mm (0–4 mm). Only three patients were still in the ‘paralytic phase’ (i.e., R = 0.4775, p = 0.0286). Conclusions The lower eyelid margin appears to shorten horizontally following FNP. This study provides proof-of-concept for the use of measuring PC distance in patients with FNP as an additional tool for the overall assessment of soft tissue contraction following FNP. It may help identify patients in whom further lower eyelid margin shortening should be avoided and in whom eyelid lengthening may be required.


  • Lower eyelid lengthening in facial nerve palsy: when is a periosteal flap required?

    by Aaron Jamison, Bhupendra C Patel, Samantha Hunt, Raman Malhotra

    Background/aims To present a case series of patients with facial nerve palsy (FNP) undergoing lower eyelid surgery where inadequate horizontal tarsal length was encountered and managed with a periosteal flap. Methods A two-centre retrospective, non-comparative case series of all patients with FNP who underwent lower eyelid periosteal flap procedures. Theatre records identified all such procedures performed by, or under the supervision of, one of two surgeons (RM, BCP) between November 2018 and November 2020. Outcome measures, including the Cornea, static Asymmetry, Dynamic function, Synkinesis grading score, were measured preoperatively and postoperatively. Results All 17 patients had undergone medial canthal tendon (MCT) plication. Six had previously undergone MCT plication then were listed for further lower eyelid surgery. In 11 cases, horizontal deficiency was encountered intraoperatively, immediately following MCT plication. Four patients were surgery-naïve. 94% were within the ‘contraction phase’ of FNP (ie, greater than 1-year duration); eight (45%) had previously undergone lower eyelid shortening procedures (such as lateral tarsal strip procedure, LTS). All patients had improved lower eyelid position postoperatively, although at 1-year postoperation, four patients require redo lower eyelid surgery. Conclusions MCT plication and stabilisation appear to be closely linked to the need for lower eyelid lengthening procedures, particularly in patients who have also undergone LTS and/or those within the ‘contraction phase’ of FNP. Unnecessary loss of horizontal tarsal length (particularly during LTS procedures) must be avoided in patients with FNP. Surgeons managing such patients should take care to identify inadvertent eyelid shortening early and be prepared to perform a lateral periosteal flap when required.


  • Do Prostaglandin Analogue Lash Lengtheners Cause Eyelid Fat and Volume Loss?

    by Aaron Jamison, Linda Okafor, Katja Ullrich, Vivian Schiedler, Raman Malhotra

    Prostaglandin analogues (PGAs; a first-line anti-glaucoma treatment) have been re-marketed as popular eyelash lengthening serums due to their lash lengthening and thickening side-effects. Periorbital volume loss is now a well-established side-effect of topical PGAs used to treated glaucoma (prostaglandin-associated periorbitopathy [PAP]) but has not, to date, been listed as a potential side-effect of lash lengthening serums containing PGA. To identify whether periorbital fat/volume loss is seen in users of prostaglandin analogue lash lengtheners. A case report and informal randomised controlled study comparing “before-and-after” colour photos displayed on the websites of PGA-containing lash lengtheners (PGALL) (i.e., containing bimatoprost, norbimatoprost, isopropyl cloprostenate, dechloro-dihydroxy-difluoro-ethylcloprostenolamide, or methylamido-dihydro-noralfaprostal), compared with two control groups: non-PGALL (NPGALL); false eyelashes (FL). Expert and layperson blinded graders used a purpose-designed grading system to identify subtle signs of periorbital fat/volume loss over time. A 35-year-old female developed thin, wrinkled, darker skin and periorbital hollowing within 10-months of using Lash Boost (Rodan & Fields, San Francisco, CA), containing isopropyl cloprostenate, which reversed six months after discontinuation. Fifteen “before-and-after” image pairs (PGALL, n=10; NPGALL, n=3; FL, n=2) were graded by five graders (three expert, two layperson). Mean grading score was 8.2 (of 19) in the PGALL group: NPGALL, 2.3; FL, 3.2. PGALL scores were significantly higher than NPGALL (pp=0.017) groups. Review of commercial “before-and-after” photos suggests PGALL users develop changes compatible with PAP. Consumers must be aware of the possibility of periorbital volume loss prior to commencing PGALLs. Often the customer-facing product ingredient list contains no mention of PGA


  • Cystic Lesion of the Optic Nerve in an Asymptomatic Adult Woman

    by Aaron Jamison, Wilma Kincaid, Vikas Chadha

    This case report describes a diagnosis of central retinal artery aneurysm of the left optic nerve head in a woman aged 54 years who presented with an asymptomat

  • Nicotinamide and Nonmelanoma Skin Cancers

    by Aaron F.R.C.Ophth. Jamison, Raman F.R.C.Ophth. Malhotra

    Oral nicotinamide supplementation may have the potential to reduce the incidence of non-melanoma skin cancers, and although currently unproven, given its favorable side effect profile, supplementation should be considered seriously, particularly in high-risk individuals.

  • Outcomes of cataract surgery in patients previously treated with orbital radiotherapy

    by Jennifer BMSc MBChB FRCOphth Hind, Aaron BSc (Hon) MBChB FRCOphth Jamison, Stefano Schipani, Julie MSc MBChB PhD FRCOphth Connolly, Paul Mbbs Frcophth Cauchi, Vikas Mbbs Chadha

    Purpose: To quantify the risks for cataract surgery in patients who have previously undergone external beam radiotherapy (EBRT). Setting: Tertiary ophthalmology and oncology hospital. Design: Retrospective case series. Methods: Patients treated with orbital EBRT at the Beatson West of Scotland Cancer Centre between 2001 and 2019 were identified, and clinical records were reviewed to identify those who had subsequently undergone cataract surgery. Preoperative and postoperative case records, and operation records, were reviewed to identify demographic data and data regarding complications and surgical outcomes. Results: 46 eyes (of 33 patients) were included. The indications for EBRT included thyroid eye disease, lymphoma, choroidal metastases, and other orbital malignancies. Mean corrected preoperative Snellen visual acuity was 20/100 (range 20/30 to 20/2000) improving to 20/25 (20/12 to 20/160, 1-way analysis of variance P < .01). Mean visual gain was 0.5 logMAR (−0.9 to 1.9). There was 1 case of posterior capsule (PC) rupture with vitreous loss (2%). Dense PC plaque was noted intraoperatively in 19.5% (n = 9). 13% (n = 6) required Nd:YAG laser posterior capsulotomy. There were 6 cases (13%) of cystoid macular edema (CME). Conclusions: Visual outcomes after cataract surgery in this cohort of patients were similar to those obtained in a nationwide cohort. EBRT seemed to be associated with an increased incidence of intraoperative PC plaque, postoperative CME (which in most cases settled with treatment), and need for posterior capsulotomy.


  • Persistent Red Eye Unresponsive to Topical Treatment

    by Aaron Jamison, Aslam Siddiqui, David Lockington

    A 68-year-old woman has a 3-week history of progressive eye redness and discomfort unresponsive to topical treatment. What would you do next?


  • Open Access

    Very late local recurrence of uveal melanoma following successful trans-scleral local resection

    by Aaron Jamison, Fiona Roberts, Wilma Kincaid, Julie Connolly, Paul Cauchi, Vikas Chadha

  • Telemedicine in Oculoplastics: The Real-Life Application of Video Consultation Clinics

    by Aaron Jamison, Charles Diaper, Suzannah Drummond, Deepak Tejwani, Maria Elena Gregory, Paul Cauchi, Kevin Crofts, Vikas Chadha

    Purpose: Our oculoplastic service piloted a new video consultation (VC) clinic in response to the COVID-19 pandemic. Data were collected to determine whether specific patients are better suited to VC, and to quantify the true benefit of VC in patients that successfully attended. Methods: Data were collected prospectively on predetermined data collection forms, including consultation duration, diagnosis, management plan, and issues that arose. Results: 37.8% of new referrals and 60.9% of return patients were vetted as suitable for VC. Of those invited to attend, 83.4% agreed to a VC appointment. Of the patients appointed to a VC clinic, 71.7% (new)/75% (return) successfully completed VC, 14.9%/15.8% attempted a VC which ultimately failed, and 13.4%/9.2% did not attend. VC successfully prevented face-to-face consultation in 81.3% of new cases and 91.1% of returns. Ectropion, entropion and dermatochalasis (new referrals), and postoperative follow-up (return patients) were well suited to VC, while patients with “watery eye” (new), and lid or conjunctival lesions (return), often required face-to-face consultation. Problems (most common issues with patients connecting to the consultation, video quality, and audio quality) were encountered during 50.3% of calls, although 82.6% of attempted calls were ultimately successful. Age was not associated with the proportion of calls that were successful. Conclusions: VC is a useful tool for oculoplastic patients, irrespective of age, as long as the patient’s notes/referrals are carefully vetted to determine suitability. Patients with ectropion, entropion and dermatochalasis, and postoperative reviews are better suited to VC than those with “watery eye,” lid lesions, and conjunctival lesions.